- Home
- Health Topics
- Articles
- Video


Isentress is a prescription drug that is used in combination with other HIV medicines to treat HIV and AIDS. This eMedTV article describes how Isentress works, offers general dosing guidelines, and provides some general precautions for the drug.
Some of the most common Isentress side effects include diarrhea, headaches, and nausea. This part of the eMedTV archives lists other common side effects of the drug and describes potentially serious side effects that may require prompt medical care.
Isentress is used for treating HIV infection and AIDS in adults. This selection from the eMedTV Web site describes how the drug works to prevent the HIV virus from multiplying and explains why the drug is not approved for use in children.
For treating HIV or AIDS in adults, the recommended Isentress dosage is one 400-mg tablet twice a day. This eMedTV segment contains other important Isentress dosing guidelines and offers tips on when and how to take the medication.
If rifampin, tipranavir, or other medications are combined with Isentress, drug interactions may occur. This eMedTV page lists the drugs that can interact with Isentress and explains how to avoid the complications these interactions may cause.
Missing Isentress doses may cause the HIV virus to become resistant to the drug. This eMedTV article takes an in-depth look at other Isentress warnings and precautions, and explains what you should tell your doctor about before starting treatment.
You should seek immediate medical attention if you believe you have taken too much Isentress. This part of the eMedTV Web site describes what to expect if you experience an Isentress overdose and discusses possible treatment options.
Isentress may not be safe for use during pregnancy. This article from the eMedTV library provides more information on Isentress and pregnancy, and describes why the FDA has classified Isentress as a pregnancy Category C medication.
Women are generally advised to avoid Isentress while breastfeeding. This eMedTV Web page contains more information about Isentress and breastfeeding, and explains why it may be dangerous to nurse an infant if you have HIV or AIDS.
October 2022 is the earliest possible date that generic Isentress could become available. This portion of the eMedTV Web site explains that patents currently prevent a generic version from being manufactured in the United States.
| Referring Pages | Articles |